A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma.

Saved in:
Bibliographic Details
Title: A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma.
Authors: Hainsworth JD (AUTHOR), Infante JR (AUTHOR), Spigel DR (AUTHOR), Arrowsmith ER (AUTHOR), Boccia RV (AUTHOR), Burris HA (AUTHOR)
Source: Cancer Investigation. Aug2011, Vol. 29 Issue 7, p451-455. 5p.
Database: Academic Search Ultimate
Description
ISSN:07357907